175 related articles for article (PubMed ID: 19710401)
1. Influence of the duplication of CFTR exon 9 and its flanking sequences on diagnosis of cystic fibrosis mutations.
El-Seedy A; Dudognon T; Bilan F; Pasquet MC; Reboul MP; Iron A; Kitzis A; Ladeveze V
J Mol Diagn; 2009 Sep; 11(5):488-93. PubMed ID: 19710401
[TBL] [Abstract][Full Text] [Related]
2. Novel CFTR Mutations in Two Iranian Families with Severe Cystic Fibrosis.
Mohseni M; Razzaghmanesh M; Parsi Mehr E; Zare H; Beheshtian M; Najmabadi H
Iran Biomed J; 2016 Sep; 20(4):201-6. PubMed ID: 27017198
[TBL] [Abstract][Full Text] [Related]
3. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
[TBL] [Abstract][Full Text] [Related]
4. mRNA-based detection of rare CFTR mutations improves genetic diagnosis of cystic fibrosis in populations with high genetic heterogeneity.
Felício V; Ramalho AS; Igreja S; Amaral MD
Clin Genet; 2017 Mar; 91(3):476-481. PubMed ID: 27174726
[TBL] [Abstract][Full Text] [Related]
5. Consequences of partial duplications of the human CFTR gene on cf diagnosis: mutations or ectopic variations.
El-Seedy A; Pasquet MC; Bienvenu T; Bieth E; Audrezet MP; Kitzis A; Ladeveze V
J Cyst Fibros; 2013 Jul; 12(4):407-10. PubMed ID: 23261175
[TBL] [Abstract][Full Text] [Related]
6. Molecular Diagnostics of Cystic Fibrosis in Serbia: Our Approach to Meet the Diagnostic Challenges.
Divac Rankov A; Kusic-Tisma J; Ljujic M; Nikolic A; Milosevic K; Vilotijevic Dautovic G; Radojkovic D
Genet Test Mol Biomarkers; 2020 Apr; 24(4):212-216. PubMed ID: 32286879
[No Abstract] [Full Text] [Related]
7. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Zielenski J; Rozmahel R; Bozon D; Kerem B; Grzelczak Z; Riordan JR; Rommens J; Tsui LC
Genomics; 1991 May; 10(1):214-28. PubMed ID: 1710598
[TBL] [Abstract][Full Text] [Related]
8. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene mutations in North Egyptian population: implications for the genetic diagnosis in Egypt.
El-Seedy A; Pasquet MC; Shafiek H; Morsi T; Kitzis A; Ladevèze V
Cell Mol Biol (Noisy-le-grand); 2016 Nov; 62(13):21-28. PubMed ID: 28040058
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous spectrum of CFTR gene mutations in Korean patients with cystic fibrosis.
Jung H; Ki CS; Koh WJ; Ahn KM; Lee SI; Kim JH; Ko JS; Seo JK; Cha SI; Lee ES; Kim JW
Korean J Lab Med; 2011 Jul; 31(3):219-24. PubMed ID: 21779199
[TBL] [Abstract][Full Text] [Related]
10. Novel and recurrent rearrangements in the CFTR gene: clinical and laboratory implications for cystic fibrosis screening.
Hantash FM; Redman JB; Starn K; Anderson B; Buller A; McGinniss MJ; Quan F; Peng M; Sun W; Strom CM
Hum Genet; 2006 Mar; 119(1-2):126-36. PubMed ID: 16362824
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel mutations in Arabs with cystic fibrosis and their impact on the cystic fibrosis transmembrane regulator mutation detection rate in Arab populations.
Kambouris M; Banjar H; Moggari I; Nazer H; Al-Hamed M; Meyer BF
Eur J Pediatr; 2000 May; 159(5):303-9. PubMed ID: 10834512
[TBL] [Abstract][Full Text] [Related]
12. Detection of large rearrangements in the cystic fibrosis transmembrane conductance regulator gene by multiplex ligation-dependent probe amplification assay when sequencing fails to detect two disease-causing mutations.
Svensson AM; Chou LS; Miller CE; Robles JA; Swensen JJ; Voelkerding KV; Mao R; Lyon E
Genet Test Mol Biomarkers; 2010 Apr; 14(2):171-4. PubMed ID: 20059381
[TBL] [Abstract][Full Text] [Related]
13. [A molecular genetic analysis of the mutations in the exons of the CFTR gene in cystic fibrosis patients in Ukraine].
Livshyts' LA
Tsitol Genet; 2000; 34(4):6-9. PubMed ID: 11033850
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous spectrum of mutations in CFTR gene from Indian patients with congenital absence of the vas deferens and their association with cystic fibrosis genetic modifiers.
Sharma H; Mavuduru RS; Singh SK; Prasad R
Mol Hum Reprod; 2014 Sep; 20(9):827-35. PubMed ID: 24958810
[TBL] [Abstract][Full Text] [Related]
15. Deletion of exons 16-17b of CFTR is frequently identified in Korean patients with cystic fibrosis.
Sohn YB; Ko JM; Jang JY; Seong MW; Park SS; Suh DI; Ko JS; Shin CH
Eur J Med Genet; 2019 Aug; 62(8):103681. PubMed ID: 31136843
[TBL] [Abstract][Full Text] [Related]
16. Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element.
Pagani F; Buratti E; Stuani C; Romano M; Zuccato E; Niksic M; Giglio L; Faraguna D; Baralle FE
J Biol Chem; 2000 Jul; 275(28):21041-7. PubMed ID: 10766763
[TBL] [Abstract][Full Text] [Related]
17. Cystic fibrosis mutation frequencies in upstate New York.
Shrimpton AE; Borowitz D; Swender P
Hum Mutat; 1997; 10(6):436-42. PubMed ID: 9401006
[TBL] [Abstract][Full Text] [Related]
18. Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides.
Igreja S; Clarke LA; Botelho HM; Marques L; Amaral MD
Hum Mutat; 2016 Feb; 37(2):209-15. PubMed ID: 26553470
[TBL] [Abstract][Full Text] [Related]
19. The c.1364C>A (p.A455E) Mutation in the CFTR Pseudogene Results in an Incorrectly Assigned Carrier Status by a Commonly Used Screening Platform.
Deeb KK; Metcalf JD; Sesock KM; Shen J; Wensel CA; Rippel LI; Smith M; Chapman MS; Zhang S
J Mol Diagn; 2015 Jul; 17(4):360-5. PubMed ID: 25956447
[TBL] [Abstract][Full Text] [Related]
20. The Genetic Analysis of Cystic Fibrosis Patients With Seven Novel Mutations in the CFTR Gene in the Central Anatolian Region of Turkey.
Erdoğan M; Köse M; Pekcan S; Hangül M; Balta B; Kiraz A; Akıncı Gönen G; Zamani AG; Yıldırım MS; Ramaslı Gürsoy T; Ezgu F; Şişmanlar Eyüpoğlu T; Tana Aslan A
Balkan Med J; 2021 Nov; 38(6):357-364. PubMed ID: 34860163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
